Dercums Disease Companies | Market Research Future

Top Industry Leaders in the Dercums Disease Market

Dercum’s Disease Key Companies *Disclaimer: List of key companies in no particular orderLatest Dercum's Disease Companies Update

May 2023: Allergan Aesthetics, an AbbVie business (NYSE: ABBV), announced that SKINVIVETM by JUVÉDERM® has received FDA approval in the United States to enhance cheek skin smoothness in individuals over 21. With benefits that last up to six months with the best care, it is the first and only intradermal microdroplet injection of hyaluronic acid (HA) for skin smoothness accessible in the United States. Smooth and injectable HA gel, SKINVIVETM by JUVÉDERM® includes a trace dose of local anesthetic lidocaine. By improving hydration and smoothing the skin, SKINVIVETM by JUVÉDERM® enhances cheek skin quality in contrast to other cosmetic injectables that accentuate and enhance the treatment region. The cream fills a significant need in the skin quality area. It is a smooth, hydrating gel that melts into the skin and is suitable for all Fitzpatrick Skin Types, from lightest to darkest.

Jan 2023: Novaliq GmbH, a biopharmaceutical company focused on first- and best-in-class ocular therapeutics, and Bausch + Lomb Corporation, an established global eye health company committed to helping people see better to live better, today announced that Ophthalmology, a peer-reviewed publication of the American Academy of Ophthalmology, recently published results from the essential Phase 3 trial GOBI, which is one of the two pivotal Phase 3 trials for NOV03 (perfluorohexyloctane). The efficacious treatment of dry eye disorder (DED) related to malfunction of the meibomian gland (MGD) is being studied with NOV03. NOV03 has been assigned a Prescription Drug User Fee Act (PDUFA) by the U.S. Food and Drug Administration (FDA).

List of Dercum's Disease Key companies in the market